 Eligible infants would be randomized within 6 hours of birth to either whole body skin cleansing with chlorhexidine specially prepared wipes releasing 0.25 chlorhexidine, or sterile water placebo. The research staff would collect the baseline data, record the axillary temperature and assess the skin condition using the Newborn Skin Condition Scoring NSCSscore. The research team would follow the infants for development of sepsis and other outcomes. The infants would be subjected to detailed sepsis work up on clinical suspicion of sepsis, until 28 days of life. 